Join the Waypoint TMS team for an informative virtual session exploring Transcranial Magnetic Stimulation (TMS), an evidence-based, non-invasive treatment option for individuals experiencing depression, particularly when traditional treatments have not provided sufficient relief.
TMS uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation and is performed while patients remain awake and able to return to their normal daily activities immediately following treatment.
This session is intended for healthcare providers, community partners, patients, families, and anyone interested in learning more about innovative approaches to treating depression.
Presenters
Katherine McKay, MD, MBA, MClSc, FRCPC, DABPN, CHE
Psychiatrist, Mobile Treatment and Support Team
Medical Director, Neuromodulation, Integrated Ambulatory and Child & Youth Services – Waypoint Centre for Mental Health Care
Jessie Daniel, MSW, RSW, CHE, Clinical Manager, OSP A & Neuromodulation
During this webinar, participants will learn:
- What TMS is and how it works
- The latest research and evidence supporting TMS for depression
- Treatment effectiveness and expected outcomes
- What patients can expect during treatment
- The role of TMS within the Difficult-to-Treat Depression (DARD) Pathway
- Eligibility considerations and referral processes
- Questions and answers with clinical experts
Key Topics
- Understanding TMS and its mechanism of action
- Research and clinical evidence supporting TMS
- TMS as a treatment option for depression
- The DARD Pathway and where TMS fits in care planning
- Patient experience and treatment expectations
- Referral and access considerations
Featured Program
TMS is a non-invasive treatment for depression that uses magnetic pulses to stimulate areas of the brain associated with mood regulation. It is publicly funded in Ontario and may be considered for adults whose depression has not adequately responded to medication or other interventions.
Registration
Join us virtually on Microsoft Teams on November 26 to learn how TMS is expanding treatment options for individuals living with depression.